Sanai Health Industry Group Company Limited, an investment holding company, engages in the manufacturing, marketing, and selling of branded prescription and non-prescription drugs, as well as Chinese pharmaceutical products in the People's Republic of China. It operates through three segments: Pharmaceutical Products, Finance Leasing, and Genetic Testing and Molecular Diagnostic Services. The company also engages in development, manufacturing, marketing, and sale of pharmaceutical products and pharmaceutical related software; and provision of consultancy services. In addition, it provides finance leasing services; and genetic testing and molecular diagnostic services. The company was incorporated in 2006 and is headquartered in Kwun Tong, Hong Kong.
Stock data | 2024 | Change |
---|---|---|
Price | $0.05337002662071271 | N/A |
Market Cap | $171.33M | N/A |
Shares Outstanding | 3.21B | N/A |
Employees | 71.00 | N/A |